ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Enrique Soto Pérez de Celis MD, PhD, FASCO

ISSN: 1754-6605

Submit article

1384-determinants-of-sexual-function-among-survivors-of-gynaecological-cancers-in-a-tertiary-hospital-a-cross-sectional-study

Research: Determinants of sexual function among survivors of gynaecological cancers in a tertiary hospital: a cross-sectional study

Maximillar Obora, Lister Onsongo, James O Ogutu

5 May 2022

https://doi.org/10.3332/ecancer.2022.1384

Abstract | Full Article | PDF

1383-genetic-polymorphisms-related-to-the-vitamin-d-pathway-in-patients-with-cirrhosis-with-or-without-hepatocellular-carcinoma-hcc

Research: Genetic polymorphisms related to the vitamin D pathway in patients with cirrhosis with or without hepatocellular carcinoma (HCC)

Beatriz de Jesus Brait, Simone Perpétua da Silva Lima, Franciana Luísa Aguiar, Rafael Fernandes-Ferreira, Camila Ive Ferreira Oliveira-Brancati, Joyce Aparecida Martins Lopes Ferraz, Graciela Domitila Tenani, Marcela Augusta de Souza Pinhel, Leticia Carolina Paraboli Assoni, Augusto Haniu Nakahara, Natalia dos Santos Jábali, Octavio Pennella Fenelon Costa, Maria Eduarda Lopes Baitello, Sidney Pinheiro Júnior, Renato Ferreira Silva, Rita de Cássia Martins Alves Silva, Doroteia Rossi da Silva Souza

4 May 2022

https://doi.org/10.3332/ecancer.2022.1383

Abstract | Full Article | PDF

1382-a-hierarchical-approach-to-combine-histological-grade-and-immunohistochemical-factors-to-identify-high-risk-luminal-breast-cancers

Research: A hierarchical approach to combine histological grade and immunohistochemical factors to identify high-risk luminal breast cancers

Felipe Andrés Cordero da Luz, Eduarda da Costa Marinho, Camila Piqui Nascimento, Lara de Andrade Marques, Patrícia Ferreira Ribeiro Delfino, Rafael Mathias Antonioli, Rogério Agenor de Araújo, Marcelo José Barbosa Silva

4 May 2022

https://doi.org/10.3332/ecancer.2022.1382

Abstract | Full Article | PDF

$1381-three-week-hypofractionated-radiotherapy-in-early-glottic-cancer-a-single-institution-retrospective-study$

Research: Three-week hypofractionated radiotherapy in early glottic cancer – a single institution retrospective study

Arun Sankar Sudha, Ravikumar Rejnish Kumar, Milan Anjanappa, Cessal Thomas Kainickal, Aleyamma Mathew, Ramadas Kunnambath

4 May 2022

https://doi.org/10.3332/ecancer.2022.1381

Abstract | Full Article | PDF

1380-pancreatic-cancer-in-the-mena-region-a-bibliometric-review

Research: Pancreatic cancer in the MENA region, a bibliometric review

Hasan Nassereldine, Hussein Awada, Adel Hajj Ali, Mohammad Zeineddine, Zahy Abdul Sater, Yasser Shaib

29 Apr 2022

https://doi.org/10.3332/ecancer.2022.1380

Abstract | Full Article | PDF

1379-timelines-to-initiate-a-phase-iii-trial-across-the-globe-a-sub-analysis-of-the-aphinity-trial

Research: Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial

Maria Alice Franzoi, Marion Procter, Chris Twelves, Noam Pondé, Daniel Eiger, Orianne Emond, Emma Clark, Damien Parlier, Sébastien Guillaume, Linda Reaby, Evandro de Azambuja, Jose Bines

29 Apr 2022

https://doi.org/10.3332/ecancer.2022.1379

Abstract | Full Article | PDF